SIRT3 and Insulin resistance: As the predominant mitochondrial NAD+-dependent deacetylase, SIRT3 serves as a metabolic gatekeeper, and is consistently found to be downregulated in clinical diabetic tissues, where its deficiency correlates with insulin resistance and disturbances in systemic energy homeostasis238-240.